4 assets in Vulvar Neoplasm

Therapeutic assets addressing Vulvar Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nivolumab Vulvar Neoplasm	Instituto do Cancer do Estado de São Paulo	P2	CCC (53)
Star0602 Vulvar Neoplasm	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Ganciclovir Vulvar Neoplasm	Gene Surgery LLC	P1	CC (47)
Stimotimagene Copolymerplasmid Vulvar Neoplasm	Gene Surgery LLC	P1	CC (47)